Methylergonovine Maleate Injection
NDC Package 51991-144-17

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Methylergonovine Maleate injection is a medication used after childbirth to help stop bleeding from the uterus. This formulation utilizes a injection delivery system. Marketed by Breckenridge Pharmaceutical, Inc., this product is identified by NDC 51991-144 and is authorized under FDA application ANDA040889.

Identification & Billing

NDC Package Code
51991-144-17
Package Description
10 AMPULE in 1 BOX / 1 mL in 1 AMPULE
Product Code
51991-144
11-Digit Billing Format
51991014417
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 996828 - methylergonovine maleate 0.2 MG in 1 ML Injection
  • RxCUI: 996828 - 1 ML methylergonovine maleate 0.2 MG/ML Injection
  • RxCUI: 996828 - methylergonovine maleate 0.2 MG per 1 ML Injection

Clinical Specifications

Proprietary Name
Methylergonovine Maleate
Non-Proprietary Name
Methylergonovine Maleate
Substance Name
Methylergonovine Maleate
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
METHYLERGONOVINE MALEATE .2 mg/mL
Pharmacologic Class
Usage Information
This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.

Regulatory & Marketing

Labeler Name
Breckenridge Pharmaceutical, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040889
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-07-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J2210
Source: ASP
Methylergonovin maleate inj
HCPCS Dosage 0.2 MG
Units / Pkg 10

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51991-144-17 identifies a specific commercial package of 10 ampule in 1 box / 1 ml in 1 ampule of Methylergonovine Maleate, a human prescription drug labeled by Breckenridge Pharmaceutical, Inc.. This injection is formulated for intravenous use and contains methylergonovine maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Breckenridge Pharmaceutical, Inc. on November 07, 2016. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.

How is this Breckenridge Pharmaceutical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51991014417. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51991-144-17
11-Digit CMS (5-4-2)
51991-0144-17

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.